Search

In this article, some investigations on the prebreakdown and breakdown phenomena of low pour point insulating liquids under negative lightning impulse (LI) voltage are reported. The tested liquids include mineral oil (MO), a typical synthetic ester (TSE), and two low-pour point synthetic esters. These liquids underwent accelerated thermal aging. The nonaged and aged samples were subjected to LIs using a point-plane electrode arrangement. The discussions are focused on the initiation of partial discharges, propagation of streamers, and breakdown behavior in the nonaged and aged liquids. The investigated parameters include inception voltage, LI breakdown voltage, streamer acceleration voltage, and streamer velocity. The results are supported by the oscillographs of the light activity that is recorded during the discharge process. The prebreakdown phenomenon noticed in the TSE vis-à-vis mineral insulating oil is in line with the existing literature. Importantly, it is noticed that the inception and breakdown voltages of the nonaged low pour point synthetic esters are similar to nonaged MO. In addition, the inception and breakdown voltages of the aged low pour point synthetic esters are noticed to be higher than that of the aged MO. These results add to the arguments in favor of replacing MOs in power transformers.

In this article, lightning impulse breakdown behaviour of two low pour point synthetic ester liquids is presented in comparison to a typical synthetic ester at both positive and negative polarities. Traditional mineral insulating oil has been also considered for reference purposes. A detailed breakdown behaviour analysis of the four test liquids under a non-uniform field (medium gap, point-plane electrode system) and quasi-uniform field (smaller gap, U-plane electrode system) is envisaged. The lightning impulse breakdown measurements based on the source voltage waveforms and light activity during the discharge process are presented. The Weibull breakdown failure rates and streamer velocity during the breakdown of different liquids for all the cases (+/- polarities and both electrode configurations) are reported in support of the discussions. In the case of non-uniform fields, the lightning breakdown voltage of the low pour point liquids is found to be higher than typical synthetic esters and is comparable to mineral oil under both polarities. While in the case of quasi-uniform field, the lightning breakdown voltage of the low pour point liquids is found to be lower than mineral oil and comparable to the typical synthetic ester under both polarities. These findings add to limited knowledge on the application of esters in cold countries and allow insulation designers to estimate the behaviour of the low pour point synthetic ester liquids under lightning conditions.

PURPOSE: The Palliative Care Study Group in conjunction with the Oral Care Study Group of the Multinational Association for Supportive Care in Cancer (MASCC) formed a sub-group to develop evidence-based guidance on the management of common oral problems in patients with advanced cancer. METHODS: This guidance was developed in accordance with the MASCC Guidelines Policy. A search strategy for Medline was developed, and the Cochrane Database of Systematic Reviews and the Cochrane Central Register of Controlled Trials were explored for relevant reviews and trials, respectively. Guidance was categorised by the level of evidence, and "category of guideline" (i.e., "recommendation", "suggestion" or "no guideline possible"). RESULTS: Twelve generic suggestions (level of evidence - 5), three problem-specific recommendations and 14 problem-specific suggestions were generated. The generic suggestions relate to oral hygiene measures, assessment of problems, principles of management, re-assessment of problems and the role of dental/oral medicine professionals. CONCLUSIONS: This guidance provides a framework for the management of common oral problems in patients with advanced cancer, although every patient requires individualised management.

Background: Telemedicine services have been increasingly used to facilitate post-treatment cancer survivorship care, including improving access; monitoring health status, health behaviors, and symptom management; enhancing information exchange; and mitigating the costs of care delivery, especially since the COVID-19 pandemic. To inform guidance for the use of telemedicine in the post-COVID era, the aim of this overview of systematic reviews (SRs) was to evaluate the efficacy of, and survivor engagement in, telemedicine interventions in the post-treatment survivorship phase, and to consider implementation barriers and facilitators. Methods: PubMed, Cochrane CENTRAL, CINAHL, Embase, and Web of Science databases were searched. SRs that examined the use of telemedicine in the post-treatment phase of cancer survivorship, published between January 2010 and April 2021, were included. Efficacy data were synthesized narratively. Implementation barriers and facilitators were synthesized using the Consolidated Framework for Implementation Research. Results: Twenty-nine SRs were included. A substantive body of evidence found telemedicine to benefit the management of psychosocial and physical effects, particularly for improving fatigue and cognitive function. There was a lack of evidence on the use of telemedicine in the prevention and surveillance for recurrences and new cancers as well as management of chronic medical conditions. This overview highlights a range of diverse barriers and facilitators at the patient, health service, and system levels. Conclusions: This review highlights the benefits of telemedicine in addressing psychosocial and physical effects, but not in other areas of post-treatment cancer survivorship care. This large review provides practical guidance for use of telemedicine in post-treatment survivorship care.

Individuals with cancer and their families assume responsibility for management of cancer as an acute and chronic disease. Yet, cancer lags other chronic diseases in its provision of proactive self-management support in routine, everyday care leaving this population vulnerable to worse health status, long-term disability, and poorer survival. Enabling cancer patients to manage the medical and emotional consequences and lifestyle and work changes due to cancer and treatment is essential to optimizing health and recovery across the continuum of cancer. In this paper, the Global Partners on Self-Management in Cancer puts forth six priority areas for action: Action 1: Prepare patients and survivors for active involvement in care; Action 2: Shift the care culture to support patients as partners in cocreating health and embed self-management support in everyday health-care provider practices and in care pathways; Action 3: Prepare the workforce in the knowledge and skills necessary to enable patients in effective self-management and reach consensus on core curricula; Action 4: Establish and reach consensus on a patient-reported outcome system for measuring the effects of self-management support and performance accountability; Action 5: Advance the evidence and stimulate research on self-management and self-management support in cancer populations; Action 6: Expand reach and access to self-management support programs across care sectors and tailored to diversity of need and stimulation of research to advance knowledge. It is time for a revolution to better integrate self-management support as part of high-quality, person-centered support and precision medicine in cancer care to optimize health outcomes, accelerate recovery, and possibly improve survival.